Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference10 articles.
1. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50(7):573–83.
2. Higuma T, Soeda T, Yamada M, et al. Does residual thrombus after aspiration thrombectomy affect the outcome of primary PCI in patients with ST-segment elevation myocardial infarction?: an optical coherence tomography study. JACC Cardiovasc Interv. 2016;9(19):2002–11. https://doi.org/10.1016/j.jcin.2016.06.050.
3. Chen Y, Zhou P, Yan H, Zhao H, Song L, Liu C, Zhao B, Chi Y, Wang S, Wang J. Impact of selective infarct-related artery infusion of tirofiban on myocardial reperfusion and bleeding complications in patients with acute myocardial infarction: the SUIT-AMI trial. J Invasive Cardiol. 2013;25(8):376–82.
4. Rezkalla SH, Stankowski RV, Hanna J, Kloner RA. Management of no-reflow phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017;10(3):215–23. https://doi.org/10.1016/j.jcin.2016.11.059.
5. ASSENT-4 Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367(9510):569–78.